IMR-687 is a highly selective, potent small molecule inhibitor of PDE9 that has a multimodal MOA that acts primarily on red blood cells and has the potential to act on white blood cells, adhesion mediators and other cell types that are implicated in sickle cell disease.
Imara, Inc.
116 Huntington Ave.
6th Floor
Boston, MA 02116
T: 617-206-2020
E: info@imaratx.com
Sign Up for Email Updates
Privacy Policy
Terms of Use
© 2020 Imara, Inc.
Links to sites outside of Imaratx.com are provided as a resource to the viewer. Imara is not responsible for and has no control over the content of linked sites.
No, I want to stay on Imaratx.com Yes, please proceed to the other site
